Join

Compare · LIVN vs MOVE

LIVN vs MOVE

Side-by-side comparison of LivaNova PLC (LIVN) and Corvex Inc. (MOVE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both LIVN and MOVE operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • LIVN is the larger of the two at $4.24B, about 128.1x MOVE ($33.1M).
  • Over the past year, LIVN is up 62.1% and MOVE is up 209.5% - MOVE leads by 147.4 points.
  • MOVE has been more active in the news (8 items in the past 4 weeks vs 5 for LIVN).
  • LIVN has more recent analyst coverage (20 ratings vs 0 for MOVE).
PerformanceLIVN+62.13%MOVE+209.49%
2025-06-10+0.00%2026-06-09
MetricLIVNMOVE
Company
LivaNova PLC
Corvex Inc.
Price
$77.19+3.15%
$17.11-3.11%
Market cap
$4.24B
$33.1M
1M return
+7.39%
+21.73%
1Y return
+62.13%
+209.49%
Sector
Health Care
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
5
8
Recent ratings
20
0
LIVN

LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

MOVE

Corvex Inc.

Movano Inc., a technology company, develops a smart wearable and continuous glucose monitoring device. Its device enables individuals and their healthcare partners to measure and manage their health conditions. Movano Inc. was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. The company was incorporated in 2018 and is based in Pleasanton, California.

Latest LIVN

Latest MOVE